Jessica Seeliger, Ph.D.

Home
Research & Reports
About Our Research
Previously Funded Researchers
Jessica Seeliger, Ph.D.

Research Project:
Targeting Latent and Multi-Drug Resistant TB

Grant Awarded:

Biomedical Research Grant

Research Topic:

basic biologic mechanisms

Research Disease:

tuberculosis

Mycobacterium tuberculosis (Mtb), infects one-third of the world's population. Most infected individuals have latent TB infections and have no symptoms. However, decreased immune responses can trigger latent TB to reactivate and cause infectious disease. Some TB disease can become resistant to first line medications and therefore, new therapies are needed to treat multi- and extremely drug-resistant TB strains. Dr. Seeliger and team will use a novel chemical method to evaluate a family of Mtb enzymes with diverse functions essential for bacterial survival as potential drug targets. These enzymes may be promising for developing next-generation therapies against latent infections and multi-drug resistant TB

Page last updated: April 30, 2024

Join the Patient & Caregiver Network

How to Help People Quit

10 Tips to Protect Yourself from Unhealthy Air

State of the Air Key Findings

Become an Advocate

Register for a LUNG FORCE Walk

Double Your Gift

Jessica Seeliger, Ph.D.

2X Your Lifesaving Impact

Make a Donation

Become a Lung Health Insider

Select Your Location

Change Language

Lung HelpLine

1-800-LUNG-USA